Double-blind, placebo-controlled phase 1 trial of nizaracianine administered in three divided doses to healthy volunteers

Authors
Category Primary study
ConferenceMolecular imaging and biology
Year 2025
This article has no abstract
Epistemonikos ID: 883ff38a87eaffc105a2bd07af2d4becc50ca46a
First added on: Feb 21, 2026